Oncology Institute, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Oncology Institute, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q3 2024.
  • Oncology Institute, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$2.26M, a 32.7% increase year-over-year.
  • Oncology Institute, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$7.07M, a 162% decline year-over-year.
  • Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2023 was -$6.09M, a 107% decline from 2022.
  • Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2022 was $81.9M, a 139% increase from 2021.
  • Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2021 was $34.3M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.07M -$2.26M +$1.1M +32.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$8.17M $885K +$2.75M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$10.9M -$1.92M -$4.83M -166% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$6.09M -$3.78M -$17.5M -128% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $11.4M -$3.36M -$20.8M -119% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $32.2M -$1.86M -$14.7M -115% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $46.8M $2.91M -$35M -92.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $81.9M $13.7M -$14.5M -51.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $96.4M $17.4M +$17.4M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $78.9M $12.8M +$7.72M +151% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $71.2M $37.9M +$37M +3791% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $34.3M $28.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$24K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $975K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.